At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 37 enrolled
Drug / intervention
Sulfur hexafluoride lipid-type A microspheresdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Role of Contrast Enhanced Ultrasound in The Diagnosis of Children With Appendicitis
In Brief
A Phase 2 clinical trial evaluating Sulfur hexafluoride lipid-type A microspheres for Acute Appendicitis. Completed, enrolled 37 participants across 1 site.
Detailed Summary
This study seeks to determine the efficacy of Contrast Enhanced Ultrasound (CEUS) in improving the diagnosis of acute appendicitis in children, when compared to the standard grey-scale ultrasound.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Appendicitis
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartJan 2019
Primary CompletionMar 2021
Study CompletionJul 2022
TodayJul 2026
First PostedSep 27, 2018
Enrollment StartJan 4, 2019
Primary CompletionMar 26, 2021
Study CompletionJul 5, 2022
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.8 years ago
Interventions
Sulfur hexafluoride lipid-type A microspheresdrug
Contrast Enhanced Ultrasound of the appendix